Search
The social context of drinking among LGBT+ people
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
Stress, Coping, and Context: Examining Substance Use Among LGBTQ Young Adults With Probable Substance Use Disorders
In this research, the authors explored how lesbian, gay, bisexual, transgender, and queer (LGBTQ) young adults with problematic substance use made sense of their substance use in relation to their LGBTQ identities.
The authors...
LGBTQ+ People and Alcohol
This briefing provides a summary of alcohol consumption, alcohol harm, alcohol treatment, and gaps in knowledge regarding alcohol use among LGBTQ+ people.
It uses the acronym LGBTQ+ to include lesbian, gay, bisexual, transgender, queer...
Substance Use in the LGBTQ+ Community: Reading List
Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) Pride month is celebrated each year during the month of June. Here you can find a list of resources and research on the topic of substance use among the LGBTQ+ community.
1) This rep...
European Drug Report 2023: Trends and Developments
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...
کام کی جگہ میں مادہ کے استعمال کی خرابی کا علاج اور روک تھام
Efectos del uso de cannabis fumada en adolescentes escolares
Reducing stigma towards people living with HIV and people who inject drugs
Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evidence exists regarding the effectiveness of...
منشیات اور شراب کے غلط استعمال کے علاج میں خاندانوں اور برادریوں کو شامل کیا جانا چاہئے
شراب اور دیگر منشیات کے علاج عام طور پر صرف ان افراد کے لئے فراہم کیے جاتے ہیں، جو اکثر ان کے خاندانوں سے دور ہوتے ہیں. علاج کا مقصد فلاح و بہبود کو بہتر بنانا اور مادہ کے استعمال کے نقصانات کو کم کرنا ہے اور خاندان اور برادریاں بحالی کے...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
72º Regular Session of the Inter-American Drug Abuse Control Comission was held
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network
The Anti-Stigma Network has been launched!
The Mission
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Comparison of Treatments for Cocaine Use Disorder Among Adults
Key Points
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Cocaine Reading List
Cocaine is an addictive stimulant drug that originates from the leaves of the coca plant, which is indigenous to South America. The drug's effects include heightened alertness, attention, and energy, as well as feelings of euphoria and...
Hexahydrocannabinol (HHC) and related substances
Introduction
The markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available.
The European situation presented in Section 1 can...
Responding to stimulant use — developments in treatment
Objective: To better understand current developments in the treatment of stimulant use.
Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member